Big data meets Big Pharma: Pfizer buys real-time patient results in collaboration with Truveta
Terry Myerson led one of the most profitable arms of Microsoft during his 21-year tenure there, having a hand in the development of Windows and Xbox software. But Myerson started out as a pre-med student before all of that and turned to life sciences investing after his stint at Microsoft ended in 2018.
Myerson is now the CEO of Truveta, a for-profit data venture backed by 20 US health systems, which was seeded from a project Myerson was working on in the midst of the pandemic with Providence, a hospital system on the West Coast. Truveta announced today a partnership with Pfizer, one that gives the Big Pharma access to real-time data on some 50 million de-identified patients.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 151,200+ biopharma pros reading Endpoints daily — and it's free.